Susquehanna International Group
CVS icon

Susquehanna International Group’s CVS Health CVS Stock Holding History

Susquehanna International Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353M Sell
4,917,000
-901,500
-15% -$69.4M 0.04% 348
2025
Q4 		$462M Sell
5,818,500
-888,200
-13% -$70M 0.05% 285
2025
Q3 		$506M Buy
6,706,700
+1,055,700
+19% +$72.4M 0.06% 256
2025
Q2 		$390M Buy
5,651,000
+325,900
+6% +$21.4M 0.05% 267
2025
Q1 		$361M Sell
5,325,100
-2,957,600
-36% -$177M 0.06% 242
2024
Q4 		$372M Buy
8,282,700
+2,199,000
+36% +$123M 0.06% 250
2024
Q3 		$383M Buy
6,083,700
+722,000
+13% +$42.1M 0.07% 242
2024
Q2 		$317M Buy
5,361,700
+1,553,700
+41% +$97.2M 0.06% 245
2024
Q1 		$304M Sell
3,808,000
-1,200,500
-24% -$91.7M 0.05% 288
2023
Q4 		$395M Sell
5,008,500
-574,300
-10% -$40.9M 0.08% 212
2023
Q3 		$390M Buy
5,582,800
+1,669,800
+43% +$118M 0.08% 182
2023
Q2 		$271M Sell
3,913,000
-187,400
-5% -$13.3M 0.06% 267
2023
Q1 		$305M Buy
4,100,400
+1,367,100
+50% +$115M 0.06% 243
2022
Q4 		$255M Buy
2,733,300
+164,500
+6% +$15.9M 0.06% 264
2022
Q3 		$245M Buy
2,568,800
+109,300
+4% +$10.8M 0.06% 242
2022
Q2 		$228M Sell
2,459,500
-1,077,700
-30% -$105M 0.06% 270
2022
Q1 		$358M Sell
3,537,200
-2,904,500
-45% -$305M 0.06% 237
2021
Q4 		$665M Sell
6,441,700
-412,800
-6% -$38.1M 0.1% 152
2021
Q3 		$582M Buy
6,854,500
+305,700
+5% +$25.6M 0.08% 197
2021
Q2 		$546M Buy
6,548,800
+295,000
+5% +$24.2M 0.08% 208
2021
Q1 		$470M Sell
6,253,800
-2,129,000
-25% -$155M 0.07% 218
2020
Q4 		$573M Sell
8,382,800
-1,632,200
-16% -$106M 0.09% 161
2020
Q3 		$585M Buy
10,015,000
+298,100
+3% +$18.5M 0.11% 121
2020
Q2 		$631M Buy
9,716,900
+1,486,100
+18% +$93.6M 0.15% 87
2020
Q1 		$488M Buy
8,230,800
+581,200
+8% +$38.8M 0.16% 102
2019
Q4 		$568M Buy
7,649,600
+3,425,400
+81% +$241M 0.16% 98
2019
Q3 		$266M Buy
4,224,200
+275,000
+7% +$16.3M 0.09% 187
2019
Q2 		$215M Buy
3,949,200
+953,100
+32% +$51.3M 0.08% 208
2019
Q1 		$162M Sell
2,996,100
-268,300
-8% -$16.6M 0.07% 246
2018
Q4 		$214M Sell
3,264,400
-565,500
-15% -$42.2M 0.09% 192
2018
Q3 		$301M Buy
3,829,900
+833,000
+28% +$59.6M 0.1% 164
2018
Q2 		$193M Buy
2,996,900
+1,535,000
+105% +$101M 0.07% 252
2018
Q1 		$90.9M Sell
1,461,900
-455,500
-24% -$32.7M 0.03% 423
2017
Q4 		$139M Buy
1,917,400
+608,800
+47% +$44.3M 0.05% 319
2017
Q3 		$106M Sell
1,308,600
-423,200
-24% -$33.5M 0.04% 361
2017
Q2 		$139M Buy
1,731,800
+726,200
+72% +$57.3M 0.06% 262
2017
Q1 		$78.9M Buy
1,005,600
+100
+0% +$7.98K 0.04% 404
2016
Q4 		$79.3M Buy
1,005,500
+30,500
+3% +$2.47M 0.04% 394
2016
Q3 		$86.8M Sell
975,000
-245,200
-20% -$23.1M 0.04% 356
2016
Q2 		$117M Buy
1,220,200
+314,000
+35% +$31.3M 0.06% 266
2016
Q1 		$94M Sell
906,200
-178,300
-16% -$17.3M 0.05% 333
2015
Q4 		$106M Sell
1,084,500
-242,700
-18% -$23.8M 0.05% 337
2015
Q3 		$128M Buy
1,327,200
+450,900
+51% +$47.4M 0.06% 305
2015
Q2 		$91.9M Buy
876,300
+293,100
+50% +$29.9M 0.04% 437
2015
Q1 		$60.2M Sell
583,200
-719,800
-55% -$72.8M 0.03% 553
2014
Q4 		$125M Buy
1,303,000
+225,800
+21% +$19.9M 0.05% 334
2014
Q3 		$85.7M Sell
1,077,200
-254,400
-19% -$20.1M 0.03% 474
2014
Q2 		$100M Buy
1,331,600
+145,400
+12% +$11M 0.04% 376
2014
Q1 		$88.8M Sell
1,186,200
-67,200
-5% -$4.75M 0.04% 385
2013
Q4 		$89.7M Sell
1,253,400
-76,000
-6% -$4.88M 0.04% 390
2013
Q3 		$75.4M Buy
1,329,400
+551,700
+71% +$32.9M 0.04% 410
2013
Q2 		$44.5M Buy
+777,700
New +$45.1M 0.03% 620

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Susquehanna International Group's CVS Position: Q1 2026 in Review

Susquehanna International Group reduced its CVS Health (CVS) stake by 74% in Q1 2026, selling an estimated $87.3M and leaving 393,977 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Susquehanna International Group first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $306M in Q2 2019. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Susquehanna International Group held 393,977 shares of CVS Health worth $28.3M as of Q1 2026.
  • Susquehanna International Group sold 1,132,833 CVS Health shares in Q1 2026, an estimated $87.3M.
  • CVS Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1803 holding.
  • Susquehanna International Group first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's CVS Health position peaked at $306M in Q2 2019.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.